Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-310298
Filing Date
2017-10-16
Accepted
2017-10-16 06:09:11
Documents
7
Period of Report
2017-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d443954d6k.htm 6-K 208330
2 GRAPHIC g443954t1.jpg GRAPHIC 8802
3 GRAPHIC g443954t2.jpg GRAPHIC 17317
4 GRAPHIC g443954t3.jpg GRAPHIC 5743
5 GRAPHIC g443954tx03.jpg GRAPHIC 19179
6 GRAPHIC g443954txpg3a.jpg GRAPHIC 27527
7 GRAPHIC g443954txpg3b.jpg GRAPHIC 9343
  Complete submission text file 0001193125-17-310298.txt   331197
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 171137536
SIC: 2834 Pharmaceutical Preparations